What is a Clinical Trial Application (CTA) and Why it Matters

What is a Clinical Trial Application (CTA) and Why it Matters Clinical trials play a vital role in the making of new medicines and treatments that lead to a healthier patient. But no new drug can be tested on human beings until the researchers in Canada get the official authority. This authorization is through a… Continue reading What is a Clinical Trial Application (CTA) and Why it Matters

Published
Categorized as Regulatory

What is a Biologics License Application (BLA) and Why is it Important in Drug Approval?

What is a Biologics License Application (BLA) and Why is it Important in Drug Approval? Have you ever thought how innovative biologic medicines like vaccines, gene therapies, or monoclonal antibodies find their way into the lab, and into the hands of patients? One key component of this process is the Biologics License Application (BLA), a… Continue reading What is a Biologics License Application (BLA) and Why is it Important in Drug Approval?

Published
Categorized as Regulatory

What Is Drug Master File (DMF) Submission

What Is Drug Master File (DMF) Submission? Drug Master File (DMF) submission is a classified document that is submitted to the U.S. Food and Drug Administration (FDA) and entails detailed data regarding the manufacturing, processing, packaging or storage of the components employed in the pharmaceutical drug products.

Published
Categorized as Regulatory

ICSR Management: Ensuring Patient Safety Through Effective Case Handling

ICSR Management: Ensuring Patient Safety Through Effective Case Handling In pharmacovigilance, adverse drug reaction (ADR) report gathering and analysis is critical to the overall protection of the health of the population. Another essential part of this initiative is the Individual Case Safety Report (ICSR) a harmonic framework of storing and reporting the suspected adverse reactions… Continue reading ICSR Management: Ensuring Patient Safety Through Effective Case Handling

Pharmacovigilance Risk Management : Protecting Patient Safety Through Proactive Strategies

Pharmacovigilance Risk Management: Protecting Patient Safety Through Proactive Strategies Pharmacovigilance is a crucial science, which secures the unnecessary safety of drugs, once they enter the market. At the core of this is risk management, which is a preventive exercise that aids in identifying, analyzing, and reducing the risk involved in pharmaceutical products. Proper risk management… Continue reading Pharmacovigilance Risk Management : Protecting Patient Safety Through Proactive Strategies

Signal Management in Pharmacovigilance: Detecting and Acting on Safety Concerns

Signal Management in Pharmacovigilance: Detecting and Acting on Safety Concerns Signal management in pharmacovigilance is a key process that facilitates safety of the patient by detecting, assessing, and controlling possible safety concerns of medicinal products. Signals are have information implying a new or modified bad event that potentially must be studied or regulated.

What is Aggregate Reporting

Aggregate Reporting in Pharmacovigilance: A Critical Compliance Requirement A legal and ethical duty of pharmaceutical companies is safety monitoring of their products during the lifecycle; the drug development and post-marketing. As Individual Case Safety Reports (ICSRs) only involve recording individual adverse events, the focus is received on a bigger picture with aggregate reporting.

Published
Categorized as Regulatory

What is Computer System Validation (CSV)

In today’s fast-evolving digital landscape, businesses increasingly rely on complex computer systems to manage critical operations, especially in regulated sectors like pharmaceuticals, biotechnology, medical devices, and manufacturing.

Published
Categorized as Quality

What is Regulatory Artwork

Regulatory artwork is crucial in the highly regulated industry of product manufacturing and distribution, and this is relevant especially in making the products comply with the legal requirements and make them available to consumers in time.

Published
Categorized as Regulatory
Book a Demo